(Especially in healthcare)
For decades, healthcare sales strategies have celebrated intuition. The best reps are described as having a "great feel for accounts," being strong relationship builders, and naturally sensing timing.
At small scale, this works. At growth scale, it breaks.
What once felt like experience-driven mastery becomes inconsistent results, unpredictable pipelines, and deals that can’t be replicated. Healthcare doesn’t punish intuition because it’s wrong. It punishes it because intuition cannot see the full ecosystem.
Intuition works locally. Healthcare buying is systemic.
Sales intuition is pattern recognition built from past interactions. It performs well when markets are flat and authority is visible.
Healthcare violates all of these conditions.
Decisions in healthcare are distributed across layers, influenced by external entities, and constrained by policy. An individual rep, no matter how skilled, only sees a slice of this system. At scale, those blind spots compound.
Intuition works when decision paths are consistent. In healthcare, ownership structures change, MSOs consolidate practices, and IDN purchasing centralizes.
What worked last year may be structurally impossible this year. Intuition lags reality because it is retrospective. Healthcare buying evolves forward. Scaling a model that relies on memory instead of current decision flow guarantees variance.
One of the most dangerous aspects of intuition-led sales is that success becomes non-transferable. Top performers often "just know" when to push.
But they can’t reliably explain which signals mattered or which stakeholders tipped the decision. This creates an organization where success can’t be taught and playbooks don’t match reality. Scaling means hiring more intuition and hoping it holds. Hope is not a GTM strategy.
Healthcare sales is less about persuasion and more about when pressure converges. Buying happens when operational pain becomes financial risk.
Intuition is notoriously poor at detecting early problem signals or cross-persona convergence. Reps engage too early and stall, or wait too long and lose priority. At scale, mistimed engagement destroys medical sales forecasting accuracy.
Individual intuition doesn’t roll up. It can’t benchmark accounts against peers or detect ecosystem-wide shifts. Leadership is left with anecdotes instead of evidence and pipeline optimism disconnected from buying reality.
Scaling requires shared visibility, not isolated judgment.
In many industries, intuition survives longer because buyers self-identify and budgets are decentralized. Healthcare is the opposite.
Authority is opaque. Risk is existential. Decisions are collective. The cost of being wrong is not just a lost deal. It is months of wasted motion across teams. Healthcare doesn’t reward gut feel. It rewards structural understanding.
Scaling healthcare sales does not mean eliminating human judgment. It means anchoring judgment in decision intelligence.
That requires:
This is where Intent.Health operates. We function before outreach, before messaging, and before execution. Not to replace reps, but to make their judgment repeatable.
Sales intuition is valuable, but only when it’s grounded in reality. In healthcare, reality is layered, authority is distributed, and intent is emergent.
Intuition alone scales chaos. Decision intelligence scales precision. And in a system as complex as U.S. healthcare, precision is the difference between growth and stagnation.